Home / Companies / Acrivon Therapeutics, Inc. / 13 Jun 2025
Acrivon Therapeutics, Inc.: meeting of 13 Jun 2025
Votes reported on Form N-PX, item by item
42 Form N-PX filers reported votes at the Acrivon Therapeutics, Inc. meeting of 13 Jun 2025. Their records fall into 2 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
3 nominees; 59.7% of reported votes for; 34 filers withheld from or voted against at least one nominee.
216 vote records from 42 filers. 15 of the 42 filers that marked the item either way voted against management.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
72 vote records from 42 filers. 0 of the 42 filers that marked the item either way voted against management.
How the largest families voted
| Family | 1. Directors | 2. Auditor |
|---|---|---|
| Vanguard | For | For |
| BlackRock and iShares | For | For |
| Fidelity | For | For |
| Dimensional | Abstain or withhold * | For |
| State Street and SPDR | For | For |
| Equitable | For | For |
| Charles Schwab | For | For |
| Nuveen and TIAA | For | For |
| ProShares and ProFunds | Abstain or withhold * | For |
| Morgan Stanley, Eaton Vance and Calvert | Abstain or withhold * | For |
| Goldman Sachs | Abstain or withhold * | For |
| Northern Trust and FlexShares | For | For |
| T. Rowe Price | For | For |
| Lincoln Financial | For | For |
| Nationwide | For | For |
| Victory Capital | Abstain or withhold * | For |
| Guggenheim and Rydex | Abstain or withhold * | For |
| Pacific Life funds | For | For |
| Global X | Abstain or withhold * | For |
| DWS | Abstain or withhold * | For |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Acrivon Therapeutics, Inc. meeting?
42 Form N-PX filers reported votes at the meeting of 13 Jun 2025. The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Acrivon Therapeutics, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Acrivon Therapeutics, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Acrivon Therapeutics, Inc. with a meeting date within three days of 13 Jun 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 30 Sep 2026.